- Home
- AVTR
AVTR
Avantor Inc.
as 05-29-2025 3:31pm EST
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
| Founded: | 1904 | Country: | United States |
| Employees: | N/A | City: | RADNOR |
| Market Cap: | 9.1B | IPO Year: | 2019 |
| Target Price: | $20.85 | AVG Volume (30 days): | 12.1M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.04 | EPS Growth: | 173.61 |
| 52 Week Low/High: | $11.82 - $28.00 | Next Earning Date: | 07-25-2025 |
| Revenue: | $6,685,200,000 | Revenue Growth: | -2.64% |
| Revenue Growth (this year): | 0.46% | Revenue Growth (next year): | 3.43% |
Stock Insider Trading Activity of Avantor Inc. (AVTR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SUMME GREGORY L | AVTR | Director | May 23 '25 | Buy | $12.50 | 30,000 | $375,000.00 | 100,000 | |
| SUMME GREGORY L | AVTR | Director | May 7 '25 | Buy | $12.00 | 25,000 | $300,000.00 | 100,000 | |
| SUMME GREGORY L | AVTR | Director | Apr 28 '25 | Buy | $12.50 | 25,000 | $312,500.00 | 100,000 | |
| Peacock Jonathan M | AVTR | Director | Apr 28 '25 | Buy | $12.81 | 8,091 | $103,645.71 | 202,715 | |
| Kang Lan | AVTR | Director | Apr 28 '25 | Buy | $12.57 | 5,000 | $62,850.00 | 35,215 |
Latest Avantor Inc. News
AVTR Breaking Stock News: Dive into AVTR Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Research Tools & Consumables Stocks Q1 Recap: Benchmarking Mettler-Toledo (NYSE:MTD)
StockStory
4 days ago
Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)
MT Newswires
7 days ago
Avantor Insider Bought Shares Worth $253,000, According to a Recent SEC Filing
StockStory
8 days ago
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
Argus Research
9 days ago
AVTR: Rating increased to a BUY
Thomson Reuters StreetEvents
13 days ago
Q1 2025 Quantum-Si Inc Earnings Call
PR Newswire
14 days ago
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
StockStory
15 days ago
Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses
Compare AVTR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVTR Avantor Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.